Integra LifeSciences Holdings Corporation (IART) Financials
IART Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.6 billion | 2.5 billion |
| March 31, 2026 | 3.6 billion | 2.5 billion |
| Dec. 31, 2025 | 3.6 billion | 2.6 billion |
| Sept. 30, 2025 | 3.6 billion | 2.6 billion |
IART Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | 37.7 million | -5.2 million |
| March 31, 2026 | -5.0 million | 5.2 million |
| Dec. 31, 2025 | -19.6 million | 5.8 million |
| Sept. 30, 2025 | 25.8 million | 5.6 million |
IART Net Income
Graph available only for paid members. Upgrade to see it.
| Date | Net Income |
|---|---|
| June 30, 2026 | 4.6 million |
| March 31, 2026 | -4.6 million |
| Dec. 31, 2025 | -1.7 million |
| Sept. 30, 2025 | -5.4 million |
IART Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 274.1 million | 1.8 billion | 174.0 million |
| March 31, 2026 | 265.5 million | 1.8 billion | 174.0 million |
| Dec. 31, 2025 | 263.7 million | 1.7 billion | 177.1 million |
| Sept. 30, 2025 | 267.9 million | 1.8 billion | 174.8 million |
IART Shares Outstanding
IART Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 14.8 million | 24.3 million | 172.4 million | - |
| March 31, 2026 | 14.8 million | 23.5 million | 178.2 million | - |
| Dec. 31, 2025 | 31.4 million | 24.8 million | 169.3 million | - |
| Sept. 30, 2025 | 15.2 million | 22.5 million | 169.0 million | - |
IART Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 418.8 million | 199.0 million |
| March 31, 2026 | 391.9 million | 167.7 million |
| Dec. 31, 2025 | 434.9 million | 219.6 million |
| Sept. 30, 2025 | 402.1 million | 176.0 million |
IART Revenue by Segment
Graph available only for paid members. Upgrade to see it.
IART
Price: $13.62
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 405021
Ebitda: 31.0 millionMarket Capitalization: 1.0 billion